These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


489 related items for PubMed ID: 24529195

  • 1. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ, Kelder JC.
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [Abstract] [Full Text] [Related]

  • 2. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ, Kelder JC.
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [Abstract] [Full Text] [Related]

  • 3. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ, Kelder JC.
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [Abstract] [Full Text] [Related]

  • 4. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R, Nyhagen C, Tabery H, Theander E.
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V, Salle V, Duhaut P, Jouen F, Smail A, Ducroix JP, Tron F, Le Loët X, Vittecoq O.
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [Abstract] [Full Text] [Related]

  • 6. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C, Mosca M, Della Rossa A, Pepe P, Notarstefano C, Ferro F, Luciano N, Talarico R, Tani C, Tavoni AG, Bombardieri S.
    Clin Exp Rheumatol; 2013 May; 31(2):272-80. PubMed ID: 23343785
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima K, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Eguchi K.
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye.
    Liew MS, Zhang M, Kim E, Akpek EK.
    Br J Ophthalmol; 2012 Dec; 96(12):1498-503. PubMed ID: 23001257
    [Abstract] [Full Text] [Related]

  • 10. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M, Nardi N, Brito-Zerón P, Aguiló S, Gil V, Delgado G, Bové A, Font J.
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [Abstract] [Full Text] [Related]

  • 11. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S, Akasbi M, Brito-Zerón P, Bosch X, Bove A, Perez-de-Lis M, Jimenez I, Soto-Cardenas MJ, Gandia M, Diaz-Lagares C, Viñas O, Siso A, Perez-Alvarez R, Yague J, Ramos-Casals M.
    Clin Exp Rheumatol; 2012 Apr; 30(5):686-92. PubMed ID: 22704838
    [Abstract] [Full Text] [Related]

  • 12. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF, Alyasky A, Elwan NM, Mourad H, Al-Bendary A.
    Egypt J Immunol; 2004 Apr; 11(1):75-81. PubMed ID: 15724389
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G, Nuñez-Alvarez C, Avila-Casado C, Llorente L, Hernández-Hernández C, Calderillo ML, Marroquín V, Recillas-Gispert C, Romero-Díaz J, Sánchez-Guerrero J.
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [Abstract] [Full Text] [Related]

  • 15. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, Alunno A, Colafrancesco S, Luciano N, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S.
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [Abstract] [Full Text] [Related]

  • 16. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
    Huo AP, Lin KC, Chou CT.
    Int J Rheum Dis; 2010 Feb 01; 13(1):39-47. PubMed ID: 20374383
    [Abstract] [Full Text] [Related]

  • 17. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.
    Kvarnström M, Ottosson V, Nordmark B, Wahren-Herlenius M.
    Scand J Rheumatol; 2015 Feb 01; 44(2):135-42. PubMed ID: 25222653
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An association of fibromyalgia with primary Sjögren's syndrome: a prospective study of 72 patients.
    Bonafede RP, Downey DC, Bennett RM.
    J Rheumatol; 1995 Jan 01; 22(1):133-6. PubMed ID: 7699659
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X.
    Ann Rheum Dis; 2005 Jan 01; 64(1):114-7. PubMed ID: 15231509
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.